Is chronic breathlessness less recognised and treated compared with chronic pain? A case-based randomised controlled trial

Zainab Ahmadi, Jacob Sandberg, Aaron Shannon-Honson, Zac Vandersman, David C. Currow, Magnus Ekström

Source: Eur Respir J, 52 (3) 1800887; 10.1183/13993003.00887-2018
Journal Issue: September
Disease area: Airway diseases

Congress or journal article abstractFull text journal articlePDF journal article, handout or slides

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Zainab Ahmadi, Jacob Sandberg, Aaron Shannon-Honson, Zac Vandersman, David C. Currow, Magnus Ekström. Is chronic breathlessness less recognised and treated compared with chronic pain? A case-based randomised controlled trial. Eur Respir J, 52 (3) 1800887; 10.1183/13993003.00887-2018

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Effectiveness of a breathlessness service for patients suffering from breathlessness in advanced disease: pragmatic fast-track randomized controlled trial
Source: Virtual Congress 2020 – New and integrated tools for respiratory diagnosis and care
Year: 2020




Sertraline in symptomatic chronic breathlessness: a double blind, randomised trial
Source: International Congress 2018 – Let’s interact and discuss the hot topics in pulmonary rehabilitation
Year: 2018




Sertraline in symptomatic chronic breathlessness: a double blind, randomised trial
Source: Eur Respir J, 53 (1) 1801270; 10.1183/13993003.01270-2018
Year: 2019



Tele-assistance in chronic respiratory failure patients: a randomised clinical trial
Source: Annual Congress 2008 - Integrated care and long-term strategies
Year: 2008


Morphine for refractory breathlessness in COPD: a randomized clinical intervention study
Source: Virtual Congress 2020 – Clinical and basic pharmacology for COPD
Year: 2020


A feasibility cluster randomised controlled trial of a paramedic-administered breathlessness management intervention for acute-on-chronic breathlessness (BREATHE)
Source: ERJ Open Res, 7 (1) 00955-2020; 10.1183/23120541.00955-2020
Year: 2021



Gefapixant in two randomised dose-escalation studies in chronic cough
Source: Eur Respir J, 55 (3) 1901615; 10.1183/13993003.01615-2019
Year: 2020



Exacerbation action plans for patients with COPD and comorbidities: a randomised controlled trial
Source: Eur Respir J, 54 (5) 1802134; 10.1183/13993003.02134-2018
Year: 2019



Effects of case management on hospitalisation and exacerbation rate in severe, complex COPD: A randomized controlled trial
Source: Annual Congress 2011 - Exacerbations and severe chronic respiratory disease: oxygen, rehabilitation, admission to hospital and palliative care
Year: 2011


Early pulmonary rehabilitation after acute exacerbation of COPD: a randomised controlled trial
Source: ERJ Open Res, 6 (1) 00173-2019; 10.1183/23120541.00173-2019
Year: 2020



Isolating peripheral effects of endogenous opioids in modulating exertional breathlessness in people with moderate or severe COPD: a randomised controlled trial
Source: ERJ Open Res, 5 (4) 00153-2019; 10.1183/23120541.00153-2019
Year: 2019



Acute effects of nasal high-flow during exercise in COPD patients after an exacerbation : a randomized controlled cross-over trial
Source: International Congress 2019 – COPD treatment: cardiovascular, oxygen and vaccination studies
Year: 2019

Patient and carer preference in two models of care for acute exacerbation of chronic obstructive pulmonary disease: results of a randomized controlled trial
Source: Eur Respir J 2001; 18: Suppl. 33, 24s
Year: 2001

A prospective randomised double-blind placebo controlled trial of venlafaxine in patients with stable chronic obstructive pulmonary disease (COPD)
Source: Eur Respir J 2006; 28: Suppl. 50, 32s
Year: 2006

Long-term efficacy of a home-based airway clearance programme to improve cough severity in patients with bronchiectasis:a randomised controlled trial>
Source: International Congress 2019 – Advances in bronchiectasis and non-TB mycobacterial infections
Year: 2019




Late Breaking Abstract - First-time assessment of efficacy of candidate vaccine to prevent acute exacerbations of chronic obstructive pulmonary disease (AECOPD): multicentre, randomised, controlled, observer-blind phase 2b trial
Source: Virtual Congress 2021 – ALERT: COPD
Year: 2021



Web-based self-management support after pulmonary rehabilitation of difficult to treat asthma: a randomised controlled trial
Source: International Congress 2017 – Techniques to treat asthma
Year: 2017

Effect of the trajectory of exertional breathlessness on symptom recall and prediction: a randomized controlled trial
Source: Virtual Congress 2020 – Comprehensive care and pulmonary rehabilitation for chronic respiratory diseases
Year: 2020


Formoterol in patients with chronic obstructive pulmonary disease: a randomized, controlled, 3-month trial.
Source: Eur Respir J 2002; 20: 245
Year: 2002


Can a six-week behaviour change intervention reduce sedentary behaviour in people with chronic obstructive pulmonary disease? A randomised controlled trial
Source: Virtual Congress 2020 – Physical activity and chronic lung disease
Year: 2020